Overcome the Difficulties in the Pandemic. Biotecan Undertook the Nucleic Acid Testing Task in Qinghuangdao24 March 2021 [BIOTECAN]
On Jan. 19, the Health Commission of Qinghuangdao published the list of nucleic acid testing institute for the public. Biotecan, assigned as the only third-party institute, undertook the nucleic acid testing mission to help the prevention of local epidemic.
On Jan. 19, The Office of Leading Group for Responding to Covid-19 Epidemic announced that everyone entering Qinghuangdao must be tested for COVID-19.
Due to the difficult situation in pandemic and the holiday of out-of-town students, the demands of nucleic acid testing increased significantly. In order to prevent and control the epidemic, as well as cutting off the potential spreading pathway of the virus, Biotecan, assigned as the only third-party institute, undertook the nucleic acid testing task to help the prevention of the epidemic.
For this task, Biotecan sent a team to Qinghuangdao with powerfully profession and well-experienced specialists from Dalian, Shanghai, Henan, and Shanxi. With the support from every department in Biotecan, our team built the mobile shelter lab strictly followed by the instruction from the local Health Commission in the shortest time, devoting to the prevention of epidemic.
The epidemic is the order and the prevention is our responsibility. Biotecan team will try our best and take the responsibility as a third-party medical lab to provide our efficient and excellent service, contributing to the epidemic prevention.
As a leading clinical molecular diagnosis enterprise, we have passed the 2020 National Health Commission's New Coronavirus Nucleic Acid Testing Laboratory Quality Assessment and Shanghai Clinical Laboratory Center's New Coronavirus Nucleic Acid Testing Capability Verification, designated by the Shanghai Municipal Health Commission as a new coronavirus nucleic acid testing agency. At the same time, our team has actively participated in the first-line anti-epidemic tasks, undertaking the COVID diagnosis and screening tasks in more than 20 cities in China, and we were honored as the Shanghai key epidemic prevention enterprise.